{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:04:29Z","timestamp":1785420269598,"version":"3.56.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,10,23]],"date-time":"2007-10-23T00:00:00Z","timestamp":1193097600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Clin Pharmacol"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The high rate of mortality due to malaria and the worldwide distribution of parasite resistance to the commonly used antimalarial drugs chloroquine and pyrimethamine emphasize the urgent need for the development of new antimalarial drugs. An alternative approach to the long and uncertain process of designing and developing new compounds is to identify among the armamentarium of drugs already approved for clinical treatment of various human diseases those that may have strong antimalarial activity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Proteasome inhibitor bortezomib (Velcade\u2122: [(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl) amino]propyl]amino]butyl] boronic acid), which has been approved for treatment of patients with multiple myeloma, and a second boronate analog Z-Leu-Leu-Leu-B(OH)<jats:sub>2<\/jats:sub> (ZL<jats:sub>3<\/jats:sub>B), were tested against four different strains of <jats:italic>P. falciparum<\/jats:italic> (3D7, HB3, W2 and Dd2) that are either sensitive or have different levels of resistance to the antimalarial drugs pyrimethamine and chloroquine.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Bortezomib and ZL<jats:sub>3<\/jats:sub>B are equally effective against drug-sensitive and -resistant parasites and block intraerythrocytic development prior to DNA synthesis, but have no effect on parasite egress or invasion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The identification of bortezomib and its analog as potent antimalarial drugs will set the stage for the advancement of this class of compounds, either alone or in combination therapy, for treatment of malaria, and emphasize the need for large-scale screens to identify new antimalarials within the library of clinically approved compounds.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1472-6904-7-13","type":"journal-article","created":{"date-parts":[[2007,10,23]],"date-time":"2007-10-23T16:40:00Z","timestamp":1193157600000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Antimalarial activity of the anticancer and proteasome inhibitor bortezomib and its analog ZL3B"],"prefix":"10.1186","volume":"7","author":[{"given":"Jennifer M","family":"Reynolds","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"El Bissati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Brandenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"G\u00fcnzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choukri Ben","family":"Mamoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,10,23]]},"reference":[{"key":"49_CR1","unstructured":"WHO Expert Committee on Malaria. World Health Organ Tech Rep Ser. 2000, 892 (i-v): 1-74."},{"issue":"1","key":"49_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1046\/j.1365-2958.2001.02222.x","volume":"39","author":"C Ben Mamoun","year":"2001","unstructured":"Ben Mamoun C, Gluzman IY, Hott C, MacMillan SK, Amarakone AS, Anderson DL, Carlton JM, Dame JB, Chakrabarti D, Martin RK, Brownstein BH, Goldberg DE: Co-ordinated programme of gene expression during asexual intraerythrocytic development of the human malaria parasite Plasmodium falciparum revealed by microarray analysis. Mol Microbiol. 2001, 39 (1): 26-36. 10.1046\/j.1365-2958.2001.02222.x.","journal-title":"Mol Microbiol"},{"issue":"2","key":"49_CR3","doi-asserted-by":"publisher","first-page":"R9","DOI":"10.1186\/gb-2003-4-2-r9","volume":"4","author":"Z Bozdech","year":"2003","unstructured":"Bozdech Z, Zhu J, Joachimiak MP, Cohen FE, Pulliam B, DeRisi JL: Expression profiling of the schizont and trophozoite stages of Plasmodium falciparum with a long-oligonucleotide microarray. Genome Biol. 2003, 4 (2): R9-10.1186\/gb-2003-4-2-r9.","journal-title":"Genome Biol"},{"issue":"6906","key":"49_CR4","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/nature01107","volume":"419","author":"L Florens","year":"2002","unstructured":"Florens L, Washburn MP, Raine JD, Anthony RM, Grainger M, Haynes JD, Moch JK, Muster N, Sacci JB, Tabb DL, Witney AA, Wolters D, Wu Y, Gardner MJ, Holder AA, Sinden RE, Yates JR, Carucci DJ: A proteomic view of the Plasmodium falciparum life cycle. Nature. 2002, 419 (6906): 520-526. 10.1038\/nature01107.","journal-title":"Nature"},{"issue":"11","key":"49_CR5","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1101\/gr.2523904","volume":"14","author":"KG Le Roch","year":"2004","unstructured":"Le Roch KG, Johnson JR, Florens L, Zhou Y, Santrosyan A, Grainger M, Yan SF, Williamson KC, Holder AA, Carucci DJ: Global analysis of transcript and protein levels across the Plasmodium falciparum life cycle. Genome Res. 2004, 14 (11): 2308-2318. 10.1101\/gr.2523904.","journal-title":"Genome Res"},{"issue":"5639","key":"49_CR6","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1126\/science.1087025","volume":"301","author":"KG Le Roch","year":"2003","unstructured":"Le Roch KG, Zhou Y, Blair PL, Grainger M, Moch JK, Haynes JD, De La Vega P, Holder AA, Batalov S, Carucci DJ, Winzeler EA: Discovery of gene function by expression profiling of the malaria parasite life cycle. Science. 2003, 301 (5639): 1503-1508. 10.1126\/science.1087025.","journal-title":"Science"},{"issue":"1","key":"49_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.molbiopara.2005.05.007","volume":"143","author":"JA Young","year":"2005","unstructured":"Young JA, Fivelman QL, Blair PL, de la Vega P, Le Roch KG, Zhou Y, Carucci DJ, Baker DA, Winzeler EA: The Plasmodium falciparum sexual development transcriptome: a microarray analysis using ontology-based pattern identification. Mol Biochem Parasitol. 2005, 143 (1): 67-79. 10.1016\/j.molbiopara.2005.05.007.","journal-title":"Mol Biochem Parasitol"},{"issue":"5","key":"49_CR8","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/S0022-2836(02)01470-5","volume":"326","author":"C Gille","year":"2003","unstructured":"Gille C, Goede A, Schloetelburg C, Preissner R, Kloetzel PM, Gobel UB, Frommel C: A comprehensive view on proteasomal sequences: implications for the evolution of the proteasome. J Mol Biol. 2003, 326 (5): 1437-1448. 10.1016\/S0022-2836(02)01470-5.","journal-title":"J Mol Biol"},{"issue":"6","key":"49_CR9","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0020-7519(00)00046-1","volume":"30","author":"GD Li","year":"2000","unstructured":"Li GD, Li JL, Mugthin M, Ward SA: Molecular cloning of a gene encoding a 20S proteasome beta subunit from Plasmodium falciparum. Int J Parasitol. 2000, 30 (6): 729-733. 10.1016\/S0020-7519(00)00046-1.","journal-title":"Int J Parasitol"},{"issue":"2","key":"49_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1471-4922(02)00064-8","volume":"19","author":"A Paugam","year":"2003","unstructured":"Paugam A, Bulteau AL, Dupouy-Camet J, Creuzet C, Friguet B: Characterization and role of protozoan parasite proteasomes. Trends Parasitol. 2003, 19 (2): 55-59. 10.1016\/S1471-4922(02)00064-8.","journal-title":"Trends Parasitol"},{"issue":"10","key":"49_CR11","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1128\/AAC.42.10.2731","volume":"42","author":"SM Gantt","year":"1998","unstructured":"Gantt SM, Myung JM, Briones MR, Li WD, Corey EJ, Omura S, Nussenzweig V, Sinnis P: Proteasome inhibitors block development of Plasmodium spp. Antimicrob Agents Chemother. 1998, 42 (10): 2731-2738.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Pt 1","key":"49_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1017\/S003118200500747X","volume":"131","author":"C Lindenthal","year":"2005","unstructured":"Lindenthal C, Weich N, Chia YS, Heussler V, Klinkert MQ: The proteasome inhibitor MLN-273 blocks exoerythrocytic and erythrocytic development of Plasmodium parasites. Parasitology. 2005, 131 (Pt 1): 37-44. 10.1017\/S003118200500747X.","journal-title":"Parasitology"},{"issue":"1","key":"49_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/sj.leu.2404444","volume":"21","author":"A Nencioni","year":"2007","unstructured":"Nencioni A, Grunebach F, Patrone F, Ballestrero A, Brossart P: Proteasome inhibitors: antitumor effects and beyond. Leukemia. 2007, 21 (1): 30-36. 10.1038\/sj.leu.2404444.","journal-title":"Leukemia"},{"issue":"6","key":"49_CR14","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1128\/AAC.46.6.2038-2040.2002","volume":"46","author":"NJ Nkemngu","year":"2002","unstructured":"Nkemngu NJ, Rosenkranz V, Wink M, Steverding D: Antitrypanosomal activities of proteasome inhibitors. Antimicrob Agents Chemother. 2002, 46 (6): 2038-2040. 10.1128\/AAC.46.6.2038-2040.2002.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"49_CR15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2174\/138920106779116865","volume":"7","author":"AM Roccaro","year":"2006","unstructured":"Roccaro AM, Hideshima T, Richardson PG, Russo D, Ribatti D, Vacca A, Dammacco F, Anderson KC: Bortezomib as an antitumor agent. Curr Pharm Biotechnol. 2006, 7 (6): 441-448. 10.2174\/138920106779116865.","journal-title":"Curr Pharm Biotechnol"},{"issue":"4254","key":"49_CR16","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1126\/science.781840","volume":"193","author":"W Trager","year":"1976","unstructured":"Trager W, Jensen JB: Human malaria parasites in continuous culture. Science. 1976, 193 (4254): 673-675. 10.1126\/science.781840.","journal-title":"Science"},{"issue":"3","key":"49_CR17","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2307\/3280287","volume":"65","author":"C Lambros","year":"1979","unstructured":"Lambros C, Vanderberg JP: Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol. 1979, 65 (3): 418-420. 10.2307\/3280287.","journal-title":"J Parasitol"},{"issue":"6","key":"49_CR18","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1128\/AAC.16.6.710","volume":"16","author":"RE Desjardins","year":"1979","unstructured":"Desjardins RE, Canfield CJ, Haynes JD, Chulay JD: Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979, 16 (6): 710-718.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"49_CR19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4269\/ajtmh.1993.48.205","volume":"48","author":"MT Makler","year":"1993","unstructured":"Makler MT, Hinrichs DJ: Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia. Am J Trop Med Hyg. 1993, 48 (2): 205-210.","journal-title":"Am J Trop Med Hyg"},{"issue":"9","key":"49_CR20","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0169-4758(98)01284-8","volume":"14","author":"MT Makler","year":"1998","unstructured":"Makler MT, Piper RC, Milhous WK: Lactate dehydrogenase and the diagnosis of malaria. Parasitol Today. 1998, 14 (9): 376-377. 10.1016\/S0169-4758(98)01284-8.","journal-title":"Parasitol Today"},{"issue":"6","key":"49_CR21","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4269\/ajtmh.1993.48.739","volume":"48","author":"MT Makler","year":"1993","unstructured":"Makler MT, Ries JM, Williams JA, Bancroft JE, Piper RC, Gibbins BL, Hinrichs DJ: Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. Am J Trop Med Hyg. 1993, 48 (6): 739-741.","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"49_CR22","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1200\/JCO.2005.03.108","volume":"23","author":"A Goy","year":"2005","unstructured":"Goy A, Younes A, McLaughlin P, Pro B, Romaguera JE, Hagemeister F, Fayad L, Dang NH, Samaniego F, Wang M, Broglio K, Samuels B, Gilles F, Sarris AH, Hart S, Trehu E, Schenkein D, Cabanillas F, Rodriguez AM: Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma. J Clin Oncol. 2005, 23 (4): 667-675. 10.1200\/JCO.2005.03.108.","journal-title":"J Clin Oncol"},{"issue":"5","key":"49_CR23","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1158\/1078-0432.CCR-06-2173","volume":"13","author":"TM Horton","year":"2007","unstructured":"Horton TM, Pati D, Plon SE, Thompson PA, Bomgaars LR, Adamson PC, Ingle AM, Wright J, Brockman AH, Paton M, Blaney SM: A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study. Clin Cancer Res. 2007, 13 (5): 1516-1522. 10.1158\/1078-0432.CCR-06-2173.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"49_CR24","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1200\/JCO.2005.02.050","volume":"23","author":"OA O'Connor","year":"2005","unstructured":"O'Connor OA, Wright J, Moskowitz C, Muzzy J, MacGregor-Cortelli B, Stubblefield M, Straus D, Portlock C, Hamlin P, Choi E, Dumetrescu O, Esseltine D, Trehu E, Adams J, Schenkein D, Zelenetz AD: Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma. J Clin Oncol. 2005, 23 (4): 676-684. 10.1200\/JCO.2005.02.050.","journal-title":"J Clin Oncol"}],"container-title":["BMC Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6904-7-13.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6904-7-13\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6904-7-13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6904-7-13.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T21:40:55Z","timestamp":1630446055000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/1472-6904-7-13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,23]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["49"],"URL":"https:\/\/doi.org\/10.1186\/1472-6904-7-13","relation":{},"ISSN":["1472-6904"],"issn-type":[{"value":"1472-6904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,23]]},"assertion":[{"value":"10 July 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"13"}}